Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line

Protein Expression and Purification
Stefan WingeOlaf Walter

Abstract

Human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII (rFVIII), is the first rFVIII produced in a human cell-line approved by the European Medicines Agency. To describe the development, upscaling and process validation for industrial-scale human-cl rhFVIII purification. The purification process involves one centrifugation, two filtration, five chromatography columns and two dedicated pathogen clearance steps (solvent/detergent treatment and 20 nm nanofiltration). The key purification step uses an affinity resin (VIIISelect) with high specificity for FVIII, removing essentially all host-cell proteins with >80% product recovery. The production-scale multi-step purification process efficiently removes process- and product-related impurities and results in a high-purity rhFVIII product, with an overall yield of ∼50%. Specific activity of the final product was >9000 IU/mg, and the ratio between active FVIII and total FVIII protein present was >0.9. The entire production process is free of animal-derived products. Leaching of potential harmful compounds from chromatography resins and all pathogens tested were below the limit of quantification in the final product. Human-cl rhFVIII can be produced at 500 L bioreactor sca...Continue Reading

References

Dec 1, 1996·Biologicals : Journal of the International Association of Biological Standardization·A R Mire-SluisR Thorpe
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·J P GirmaD Meyer
Sep 8, 2001·Seminars in Thrombosis and Hemostasis·B G Boedeker
Apr 23, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·R JiangP J Larson
Jun 29, 2004·Journal of Thrombosis and Haemostasis : JTH·S C DarbyUNKNOWN UK Haemophilia Centre Doctors' Organisation
Jan 22, 2005·Haemophilia : the Official Journal of the World Federation of Hemophilia·K FischerH M Berg
Sep 21, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·M MorfiniJ Tusell
Aug 5, 2008·Biologicals : Journal of the International Association of Biological Standardization·Peter L Roberts
May 29, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·T M BrownC L Pashos
Nov 13, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·L ThimT D Steenstrup
Jan 1, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·B KelleyJ Booth
Jan 1, 2010·Journal of Blood Medicine·Antonio CoppolaAnna Maria Cerbone
Jun 14, 2012·European Journal of Haematology·Elisabeth CasademuntCarola Schröder
Jun 29, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·J Astermark
Jan 18, 2013·The New England Journal of Medicine·Samantha C GouwUNKNOWN PedNet and RODIN Study Group
Dec 18, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A ValentinoS Knaub
May 9, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·J McCueD Euwart

❮ Previous
Next ❯

Citations

Aug 23, 2016·Expert Opinion on Emerging Drugs·Massimo Morfini, Ezio Zanon
Oct 21, 2016·Biotechnology Journal·Timothy M PabstAlan K Hunter
Jan 20, 2017·Expert Opinion on Drug Safety·Massimo Franchini, Pier Mannuccio Mannucci
Apr 28, 2020·Haemophilia : the Official Journal of the World Federation of Hemophilia·Jayashree MotwaniGerald Spotts
Jan 22, 2017·Journal of Thrombosis and Haemostasis : JTH·S A ShestopalA G Sarafanov
May 5, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·D BaunsgaardM Ezban
Dec 21, 2016·Haemophilia : the Official Journal of the World Federation of Hemophilia·S GargerW Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Bioreactors (ASM)

Bioreactors are important devices or systems that utilize living cells or enzymes for a chemical process. These devices carefully control and monitor the environment factors such as pH, nutrients level, and temperature, which can affect the yield in a given process. Discover the latest research here.